Urinary Side Effects and Complications After Permanent Prostate Brachytherapy: The MD Anderson Cancer Center Experience

Urology

Volumn 74, Issue 3, 2009, Pages 601-605

  Anderson, John F ^a   Swanson, David A ^a   Levy, Lawrence B ^a   Kuban, Deborah A ^a   Lee, Andrew K ^a   Kudchadker, Rajat ^a   Phan, Jack ^a   Bruno, Teresa ^a   Frank, Steven J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125;

ARTICLE; BRACHYTHERAPY; CANCER CENTER; CATHETERIZATION; CONTROLLED STUDY; DYSURIA; HEALTH SURVEY; HEMATURIA; HEMORRHAGIC CYSTITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; TERTIARY HEALTH CARE; URETHRA STRICTURE; URINARY TRACT OBSTRUCTION; URINE INCONTINENCE; URINE RETENTION;

ACUTE DISEASE; BRACHYTHERAPY; FOLLOW-UP STUDIES; HUMANS; MALE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TIME FACTORS; URINATION DISORDERS;

EID: 69249202338     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.04.060     Document Type: Article

References (21)

1. Cesaretti J., Stone N., Skouteris V., et al. Brachytherapy for the treatment of prostate cancer. Cancer J 13 (2007) 302-312
2. Frank S.J., Levy L.B., Kuban D.A., et al. Prostogram-predicted brachytherapy outcomes may not be universally accurate: an analysis based on the M.D. Anderson Cancer Center experience with iodine-125 brachytherapy. J Urol 181 (2009) 1658-1663
3. Bottomley D., Ash D., Al-Qaisieh B., et al. Side effects of permanent I 125 prostate seed implants in 667 patients treated in Leeds. Radiother Oncol 82 (2007) 46-49
4. Frank S.J., Pisters L., Davis J., et al. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol 177 (2007) 2151-2156
5. Chen A.B., D'Amico A.V., Neville B.A., et al. Patient and treatment factors associated with complications after prostate brachytherapy. J Clin Oncol 24 (2006) 5298-5304
6. Shakespeare D., Mitchell D.M., Carey B.M., et al. Recto-urethral fistula following brachytherapy for localized prostate cancer. Colorectal Dis 9 (2007) 328-331
7. Sarosdy M.F. Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy. Cancer 101 (2004) 754-760
8. Chrouser K.L., Leibovich B.C., Sweat S.D., et al. Urinary fistulas following external radiation or permanent brachytherapy for the treatment of prostate cancer. J Urol 173 (2005) 1953-1957
9. Henderson A., Ismail A., Cunningham M., et al. Toxicity and early biochemical outcomes from 125iodine prostate brachytherapy in the UK: a prospective study. Clin Oncol (R Coll Radiol) 16 (2004) 95-104
10. Moreira Jr. S.G., Seigne J.D., Ordorica R.C., et al. Devastating complications after brachytherapy in the treatment of prostate adenocarcinoma. BJU Int 93 (2004) 31-35
11. Wei J., Dunn R., Litwin M., et al. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56 (2000) 899-905
12. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
13. Pavy J.J., Denekamp J., Letschert J., et al., EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Radiother Oncol 35 (1995) 11-15
14. Cheung M.R., Tucker S.L., Dong L., et al. Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 67 (2007) 1059-1065
15. National Cancer Institute Common terminology criteria for adverse events v3.0. Available at: https://webapps.ctep.nci.nih.gov/webobjs/ctc/webhelp/welcome_to_ctcae.htm.
16. Stone N.N., and Stock R.G. Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years. Urology 69 (2007) 338-342
17. Merrick G.S., Butler W.M., Wallner K.E., et al. The impact of radiation dose to the urethra on brachytherapy-related dysuria. Brachytherapy 4 (2005) 45-50
18. Crook J., Fleshner N., Roberts C., et al. Long-term urinary sequelae following 125Iodine prostate brachytherapy. J Urol 179 (2008) 141-146
19. Sanda M.G., Dunn R.L., Michalski J., et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358 (2008) 1250-1261
20. Merrick G.S., Butler W.M., Wallner K.E., et al. Effect of transurethral resection on urinary quality of life after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 58 (2004) 81-88
21. Kopllmeier M.A., Stock R.G., Cesaretti J., et al. Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy. J Urol 173 (2005) 808-812